Variant position: 523 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 651 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human SAALLAPHLIGEFLTLVLLG IVQNPNIVNSVVAL-LSIAGVL
Mouse SAALLAPHLIGEFLTLVLLG IVQNPNIVNSIVAL-LSISGL
Rat SAALLAPHLIGEFLTLVLLG MVQNPNIVNSIVAL-LSISGL
Slime mold LFIFIITYIMYDAFALCLAV CLPNEVMASTICGIGLSLATL
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 651 ATP-binding cassette sub-family G member 5
522 – 528 Cytoplasmic
388 – 645 ABC transmembrane type-2
540 – 540 A -> F. Strongly decreases cholesterol secretion into bile.
Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia.
Hubacek J.A.; Berge K.E.; Cohen J.C.; Hobbs H.H.;
Hum. Mutat. 18:359-360(2001)
Cited for: VARIANT STSL2 LYS-437; VARIANTS VAL-523; TYR-600; GLU-604 AND VAL-622;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.